Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability

REFERENCES

• Arnold, C. S., Johnson R. N., Cole D. L., Lee M., and Hart G. W.. 1996. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J. Biol. Chem. 271:28741–28742.
   PubMed Web of Science ®Google Scholar
• Berton, F., Cornet V., Iborra C., Garrido J., Dargent B., Fukuda M., Seagar M., and Marqueze B.. 2000. Synaptotagmin I and IV define distinct populations of neuronal transport vesicles. Eur. J. Neurosci. 12:1294–1302.
   PubMedGoogle Scholar
• Brich, J., Shie F.-S., Howell B. W., Li R., Tus K., Wakeland E. K., Jin L.-W., Mumby M., Churchill G., Herz J., and Cooper J. A.. 2003. Genetic modulation of tau phosphorylation in the mouse. J. Neurosci. 23:187–192.
   PubMedGoogle Scholar
• Chou, T. Y., Dang C. V., and Hart G. W.. 1995. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. USA 92:4417–4421.
   PubMedGoogle Scholar
• Coats, S., Flanagan W. M., Nourse J., and Roberts J. M.. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877–880.
   PubMed Web of Science ®Google Scholar
• Cole, R. N., and Hart G. W.. 1999. Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin I interactions. J. Neurochem. 73:418–428.
   PubMedGoogle Scholar
• Comer, F. I., Vosseller K., Wells L., Accavitti M. A., and Hart G. W.. 2001. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal. Biochem. 293:169–177.
   PubMedGoogle Scholar
• Comer, F. I., and Hart G. W.. 2001. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40:7845–7852.
   PubMed Web of Science ®Google Scholar
• Datta, R., Choudhury P., Gosh A., and Datta B.. 2003. A glycosylation site, 60SGTS63, of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2α. Biochemistry 42:5453–5460.
   PubMed Web of Science ®Google Scholar
• de Alboran, I. M., O'Hagan R. C., Gärtner F., Malynn B., Davidson L., Rickert R., Rajewsky K., DePinho R. A., and Alt F. W.. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14:45–55.
   PubMed Web of Science ®Google Scholar
• DeFalco, J., Tomishima M., Liu H., Zhao C., Cai X., Marth J. D., Enquist L., and Friedman J. M.. 2001. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science 291:2608–2613.
   PubMed Web of Science ®Google Scholar
• Ding, M., and Vandre D. D.. 1996. High molecular weight microtubule-associated proteins contain O-linked-N-acetylglucosamine. J. Biol. Chem. 271:12555–12561.
   PubMed Web of Science ®Google Scholar
• Eisenman, R. N. 2001. Deconstructing Myc. Genes Dev. 15:2023–2030.
   PubMed Web of Science ®Google Scholar
• Frels, W. I., and Chapman V. M.. 1980. Expression of the maternally derived X chromosome in the mural trophoblast of the mouse. J. Embryol. Exp. Morphol. 56:179–190.
   PubMedGoogle Scholar
• Gabriel, A., Helman T., and Wilks A.. 1993. A PCR based assay for the murine multiple intestinal neoplasia (Min) mutation. Mouse Genome 91:316–320.
   Google Scholar
• Gao, Y., Wells L., Comer F. I., Partker G. J., and Hart G. W.. 2001. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276:9838–9845.
   PubMed Web of Science ®Google Scholar
• Haltiwanger, R. S., Blomberg M. A., and Hart G. W.. 1992. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase. J. Biol. Chem. 267:9005–9013.
   PubMed Web of Science ®Google Scholar
• Haltiwanger, R. S., Grove K., and Philipsberg G. A.. 1998. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273:3611–3617.
   PubMed Web of Science ®Google Scholar
• Han, I., and Kudlow J. E.. 1997. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 17:2550–2558.
   PubMedGoogle Scholar
• Hanahan, D., Lane D., Lipsich L., Wigler M., and Botchan M. 1980. Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell. Cell 21:127–139.
   PubMed Web of Science ®Google Scholar
• Harper, M., Fosten M., and Monk M.. 1982. Preferential paternal X inactivation in extra-embryonic tissues of early mouse embryos. J. Embryol. Exp. Morphol. 67:127–135.
   PubMedGoogle Scholar
• Hart, G. W. 1997. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 66:315–335.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and Reed S. I.. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861–1864.
   PubMed Web of Science ®Google Scholar
• Hennet, T., Hagen F. K., Tabak L. A., and Marth J. D.. 1995. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92:12070–12074.
   PubMedGoogle Scholar
• Kamemura, K., Hayes B. K., Comer F. I., and Hart G. W.. 2002. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J. Biol. Chem. 277:19229–19235.
   PubMed Web of Science ®Google Scholar
• Kearse, K. P., and Hart G. W.. 1991. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc. Natl. Acad. Sci. USA 88:1701–1705.
   PubMedGoogle Scholar
• Kelly, W. G., Dahmus M. E., and Hart G. W.. 1993. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J. Biol. Chem. 268:10416–10424.
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., Nakano H., Hayashi M., Shimazaki M., Fukutani Y., Sasaki K., Sugimori K., and Koshino Y.. 2003. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J. Neurol. Sci. 208:17–24.
   PubMed Web of Science ®Google Scholar
• Kreppel, L. K., Blomberg M. A., and Hart G. W.. 1997. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 272:9308–9315.
   PubMed Web of Science ®Google Scholar
• Kreppel, L. K., and Hart G. W.. 1999. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 274:32015–32022.
   PubMed Web of Science ®Google Scholar
• Kunieda, T., Xian M., Kobayashi E., Imamichi T., Moriwaki K., and Toyoda Y.. 1992. Sexing of mouse preimplantation embryos by detection of Y chromosome-specific sequences using polymerase chain reaction. Biol. Reprod. 46:692–697.
   PubMedGoogle Scholar
• Lavrovsky, Y., Song C.-S., Chatterjee B., and Roy A. K.. 1998. A rapid and reliable PCR-based assay for gene transmission and sex determination in newborn transgenic mice. Transgenic Res. 7:319–320.
   PubMedGoogle Scholar
• Liu, F., Iqbal K., Grundke-Iqbal I., and Gong C. X.. 2002. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3 beta. FEBS Lett. 530:209–214.
   PubMed Web of Science ®Google Scholar
• Longo, L., Vanegas O. C., Patel M., Rosti V., Li H., Waka J., Merghoub T., Pandolfi P. P., Notaro R., Manova K., and Luzzatto L.. 2002. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J. 21:4229–4239.
   PubMed Web of Science ®Google Scholar
• Lubas, W. A., Frank D. W., Krause M., and Hanover J. A.. 1997. O-linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272:9316–9324.
   PubMed Web of Science ®Google Scholar
• Lubas, W. A., and Hanover J. A.. 2000. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J. Biol. Chem. 275:10983–10988.
   PubMed Web of Science ®Google Scholar
• Marek, K. W., Vijay I., and Marth J. D.. 1999. A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology 9:1263–1271.
   PubMedGoogle Scholar
• Marth, J. D. 1996. Recent advances in gene mutagenesis by site-specific recombination. J. Clin. Investig. 97:1999–2002.
   PubMedGoogle Scholar
• McClain, D. A., Lubas W. A., Cooksey R. C., Hazel M., Parker G. J., Love D. C., and Hanover J. A.. 2002. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc. Natl. Acad. Sci. USA 99:10695–10699.
   PubMed Web of Science ®Google Scholar
• Miller, M. W., Caracciolo M. R., Berlin W. K., and Hanover J. A.. 1999. Phosphorylation and glycosylation of nucleoporins. Arch. Biochem. Biophys. 367:51–60.
   PubMedGoogle Scholar
• Nemeth, A. H., Nolte D., Dunne E., Niemann S., Kostrzewa M., Peters U., Fraser E., Bochukova E., Butler R., Brown J., Cox R. D., Levy E. R., Ropers H. H., Monaco A. P., and Muller U.. 1999. Refined linkage disequilibrium and physical mapping of the gene locus for X-linked dystonia-parkinsonism (DYT3). Genomics 60:320–329.
   PubMedGoogle Scholar
• O'Gorman, S., Dagenais N. A., Qian M., and Marchuk Y.. 1997. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. USA 94:14602–14607.
   PubMedGoogle Scholar
• Pagano, M., Tam S. W., Theodoras A. M., Beer-Romero P., De Sal G., Chau V., Yew P. R., Draetta G. F., and Rolfe M.. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685.
   PubMed Web of Science ®Google Scholar
• Priatel, J. J., Chui D., Hiraoka N., Simmons C. J. T., Richardson K. B., Page D. M., Fukuda M., Varki N. M., and Marth J. D.. 2000. The ST3Gal-l sialyltransferase controls CD8+ T lymphocyte homeostatis by modulating O-glycan biosynthesis. Immunity 12:273–283.
   PubMed Web of Science ®Google Scholar
• Roos, M. D., Su S., Baker J. R., and Kudlow J. E.. 1997. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17:6472–6480.
   PubMedGoogle Scholar
• Shafi, R., Iyer S. P., Ellies L. G., O'Donnell N., Marek K. W., Chui D., Hart G. W., and Marth J. D.. 2000. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. USA 97:5735–5739.
   PubMed Web of Science ®Google Scholar
• Shaulian, E., and Karin M.. 2001. AP-1 in cell proliferation and survival. Oncogene 20:2390–2400.
   PubMed Web of Science ®Google Scholar
• Su, K., Yang X., Roos M. D., Paterson A. J., and Kudlow J. E.. 2000. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem. J. 348:281–289.
   PubMedGoogle Scholar
• Toyoshima, H., and Hunter T.. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67–74.
   PubMed Web of Science ®Google Scholar
• Vosseller, K., Wells L., Lane M. D., and Hart G. W.. 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 99:5313–5318.
   PubMed Web of Science ®Google Scholar
• Wells, L., and Hart G. W.. 2003. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytoplasmic proteins with a sugar. FEBS Lett. 546:154–158.
   PubMed Web of Science ®Google Scholar
• Yang, X., Su K., Roos M. D., Chang Q., Paterson A. J., and Kudlow J. E.. 2001. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 98:6611–6616.
   PubMed Web of Science ®Google Scholar
• Yang, X., Zhang F., and Kudlow J. E.. 2002. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110:69–80.
   PubMed Web of Science ®Google Scholar
• Yee, J.-K., Miyanohara A., LaPorte P., Bouic K., Burns J. C., and Friedman T.. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564–9568.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., Romero M. I., Ghosh P., Ye Z., Charnay P., Rushing E. J., Marth J. D., and Parada L. F.. 2001. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 15:859–876.
   PubMedGoogle Scholar